THE BEST SIDE OF LUMACAFTOR

CRC has an immunosuppressive TME which stops the event of an effective reaction to ICB therapies. There exists Consequently an urgent need to recognize the techniques reprogram this suppressive TME so as to enhance immunotherapy efficacy. In the current examine, we utilized CRISPR KO screens to find genes that sensitize CRC to antitumor immunity in